Liliemark E - Search Results

1

In vitro topo II--DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia.

Wang Y, Zhou R, Liliemark J, Gruber A, Lindemalm S, Albertioni F, Liliemark E. Wang Y, et al. Among authors: liliemark e. Leuk Res. 2001 Feb;25(2):133-40. doi: 10.1016/s0145-2126(00)00103-x. Leuk Res. 2001. PMID: 11166828

2

Real-time RT-PCR for the determination of topoisomerase II mRNA level in leukaemic cells.

Zhou R, Frostvik Stolt M, Kronenwett U, Gruber A, Liliemark J, Liliemark E. Zhou R, et al. Among authors: liliemark e. Leuk Res. 2002 May;26(5):487-94. doi: 10.1016/s0145-2126(01)00144-8. Leuk Res. 2002. PMID: 11916525

3

In vivo accumulation of etoposide in peripheral leukemic cells in patients treated for acute myeloblastic leukemia; relation to plasma concentrations and protein binding.

Liliemark EK, Liliemark J, Pettersson B, Gruber A, Björkholm M, Peterson C. Liliemark EK, et al. Among authors: liliemark j. Leuk Lymphoma. 1993 Jul;10(4-5):323-8. doi: 10.3109/10428199309148555. Leuk Lymphoma. 1993. PMID: 8220130

4

Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia--relationship to treatment outcome and bone marrow toxicity.

Gruber A, Liliemark E, Tidefelt U, Paul C, Björkholm M, Peterson C, Liliemark J. Gruber A, et al. Among authors: liliemark j, liliemark e. Leuk Res. 1995 Oct;19(10):757-61. doi: 10.1016/0145-2126(95)00061-r. Leuk Res. 1995. PMID: 7500654

5

High-performance liquid chromatography with fluorometric detection for monitoring of etoposide and its cis-isomer in plasma and leukaemic cells.

Liliemark E, Pettersson B, Peterson C, Liliemark J. Liliemark E, et al. Among authors: liliemark j. J Chromatogr B Biomed Appl. 1995 Jul 21;669(2):311-7. doi: 10.1016/0378-4347(95)00113-w. J Chromatogr B Biomed Appl. 1995. PMID: 7581907

6

Higher in vivo protein binding of etoposide in children compared with adult cancer patients.

Liliemark E, Söderhäll S, Sirzea F, Gruber A, Osby E, Björkholm M, Zhou R, Peterson C, Liliemark J. Liliemark E, et al. Among authors: liliemark j. Cancer Lett. 1996 Aug 23;106(1):97-100. doi: 10.1016/0304-3835(96)04308-x. Cancer Lett. 1996. PMID: 8827052

7

Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL.

Zhou R, Vitols S, Gruber A, Liliemark J, Wang Y, Liliemark E. Zhou R, et al. Among authors: liliemark j, liliemark e. Br J Haematol. 1999 May;105(2):420-7. Br J Haematol. 1999. PMID: 10233413 Free article.

8

Topoisomerase II-mediated alterations of K562 drug resistant sublines.

Zhou R, Wang Y, Gruber A, Larsson R, Castaños-Vèlez E, Liliemark E. Zhou R, et al. Among authors: liliemark e. Med Oncol. 1999 Sep;16(3):191-8. doi: 10.1007/BF02906131. Med Oncol. 1999. PMID: 10523799

9

Reduced DNA ligase activity in etoposide resistant human lymphatic leukaemia CEM cells.

Fredriksson E, Liliemark E, Polischouk A, Soderhall S, Albertioni F, Ljungquist S. Fredriksson E, et al. Among authors: liliemark e. Biochem Pharmacol. 2002 Jan 15;63(2):259-64. doi: 10.1016/s0006-2952(01)00842-5. Biochem Pharmacol. 2002. PMID: 11841801

10

Ultrafiltration and subsequent high performance liquid chromatography for in vivo determinations of the protein binding of etoposide.

Liliemark E, Herngren L, Pettersson B, Peterson C, Liliemark J. Liliemark E, et al. Among authors: liliemark j. Cancer Lett. 1996 Aug 23;106(1):91-6. doi: 10.1016/0304-3835(96)04307-8. Cancer Lett. 1996. PMID: 8827051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters